No abstract available.
Hashimoto Disease*

No abstract available.
Hashimoto Disease ; Myotonia

125 patients with Basedow disease associated with Hashimoto disease were investigated (in comparative with 88 patients subfering from single Basedow disease) at Military Hospital No 103 from January 1996 to June 2002. Results showed no difference between two groups in terms of the age of disease developing thyroid tumor of 3nd grade was occurred usually in both 2 groups, while the tumor of 4th grade occurred usually in the group of Basedow associated with Hashimoto disease. The tumor of Basedow associated with Hashimoto disease used to get high intensity, harderning in the grey and rose color while in the patient with simple Basedow disease, the tumor had low intensity, soft consistency and purple color.
Diagnosis ; Graves Disease ; Hashimoto Disease

At the Hospital N0103, the characteristics of basedow symptoms were studied in 125 patients with basedow in combining with Hashimoto disease in comparing with 88 patients of simple basedow. Results showed no obvious difference between simple basedow patients and basedow associated with Hashimoto in terms of age of developing disease, of peripheral white blood cells, of basal metabolism, electro heart rate, T3, T4, FT4 level and Thyrotropin. 100% of patients who were diagnosed pathoanatomically as basedow in combining with Hashimoto, were diagnosed clinically as simple basedow. 98.8% of patients of basedow in combining with Hashimoto who underwent a biopsy of cell aspiration had got confirmed diagnosis
Thyroiditis, Autoimmune ; Graves Disease ; Hashimoto Disease

No abstract available.
Autoantibodies ; Brain Diseases ; Hashimoto Disease ; Status Epilepticus

No abstract available.
Brain Diseases ; Hashimoto Disease ; Tuberculosis, Meningeal

Cytokines ; Hashimoto Disease ; diagnosis ; prevention & control ; Humans

To systemically evaluate the clinical efficacy and safety of oral preparation of Xiakucao with levothyroxine(LT4) on Hashimoto's thyroiditis(HT), so as to provide the evidence for its clinical application in the future. All the included studies were retrieved from four Chinese databases and three English databases from their inception to December 2019. ROB assessment tool of cochrane system and the evidence classification recommended by GRADE were used to evaluate the quality of evidences in all included studies. RevMan 5.3 was used for Meta-analysis of the outcomes. Software TSA 0.9(trail sequential analysis) was used to estimate the sample size for Meta-analysis. The results showed that 11 randomized controlled trials and totaling 1 215 patients were included. Preparation of Xiakucao combined with LT4 was adopted as intervention in experimental group, while patients in control group were treated with LT4 alone. Meta-analysis results showed that as compared with control group, the rate of total efficacy in experimental group was significant improved, including improvement of thyroid function and thyroid autoantibodies, shrinkage of thyroid gland and nodule, and improvement of clinical symptoms such as fatigue and cold intolerance(RR=1.15, 95%CI[1.09, 1.21]). The experimental group significantly decreased the serum level of thyroperoxidase antibody TPO-Ab(SMD=-0.91, 95%CI[-1.40,-0.41]), and reduced the size of left thyroid lobe(MD=-1.46, 95%CI[-1.82,-1.11]), right thyroid lobe(MD=-1.45, 95%CI[-1.96,-0.94]) and isthmus of thyroid gland(MD=-1.08, 95%CI[-1.20,-0.95]). After evaluation based on GRADEpro, the results showed that the evidence quality of all included studies was low or very low. The result of TSA showed that the cumulative sample size had reached the expected value. However, the pooled results may be affected by one study with high bias risk, with not so high effect intensity of evidences. From this review, we can see that in treatment of HT, intervention of preparation of Xiakucao combined with LT4 has advantages on improvement of clinical efficiency, decreasing serum level of TPO-Ab and shrinkage of thyroid gland. However, due to the quality of evidence, more rigorously designed and high-quality trials are needed in the future to verify the clinical efficacy and safety of preparation of Xiakucao in treating HT.
Hashimoto Disease ; Humans ; Iodide Peroxidase ; Prunella ; Thyroxine

Riedel thyroiditis is a benign disease, which is often self-limited. Examinations, such as CT and histologic diagnosis can distinguish it from malignant neoplasms and hashimoto's thyroiditis. Riedel thyroiditis is an uncommon form of chronic thyroiditis in which the thyroid gland is replaced by fibrous tissue. It can be cured by surgery and medicine.
Chronic Disease ; Diagnosis, Differential ; Hashimoto Disease ; diagnosis ; Humans ; Thyroiditis ; diagnosis

Hashimoto encephalopathy shares common clinical features with Creutzfeldt-Jakob disease and must be regarded as a differential diagnosis because of its good prognosis. We report a case of Hashimoto encephalopathy, which had not been recognized before the diagnosis of Creutzfeldt-Jakob disease. The electroclinical findings were compatible with probable Creutzfeldt-Jakob disease and coexistence of Hashimoto thyroiditis was supported by high titers of anti-thyroid microsomal antibody and cytopathologic findings. Hashimoto encephalopathy was not improved, which was most likely due to the coexistence of Creutzfeldt-Jakob disease.
Creutzfeldt-Jakob Syndrome* ; Diagnosis ; Diagnosis, Differential ; Hashimoto Disease ; Prognosis